Astragalus ameliorates oxidative stress in rat models of preeclampsia through the Nrf2/Keap1/NQO1 pathway
Placenta · 2025-08 · 168 · 232-239
DOI: 10.1016/j.placenta.2025.07.004 ↗Kurz gefasst
Fachartikel in der Zeitschrift Placenta, 2025-08. Verfasst von Lijun Yang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics, First Clinical College of Shanxi Medical University, Taiyuan, Shanxi Province, PR China. Hauptthemen laut MEDLINE: Oxidative Stress, Pre-Eclampsia, Astragalus Plant, Plant Extracts. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 50 Literaturangaben. Gefördert von: Non-US Government Research Support type, Shanxi Province Natural Science Foundation, Shanxi Medical University.
Abstract (Originalsprache)
BACKGROUND: Preeclampsia (PE) is a high-risk complication that endangers both maternal and fetal health. Astragalus species exhibit potent antioxidant effects, which have been explored in the management of diverse diseases. STUDY OBJECTIVE: This research aimed to explore the possible therapeutic benefits of Astragalus using a rat model of PE induced by NG-nitro-L-arginine methyl ester (L-NAME). METHODS: Key parameters assessed in pregnant rats included 24-h urinary protein, blood pressure, placental morphology (diameter and weight), and fetal outcomes (pup length, weight, and malformation rate). Serum placental growth factor (PLGF) and soluble fms-like tyrosine kinase-1 (sFlt-1) were analyzed via enzyme-linked immunosorbent assay (ELISA). Oxidative stress markers-malondialdehyde (MDA) and glutathione peroxidase (GSH-Px)-were measured in placental tissue and serum, while catalase (CAT) and superoxide dismutase (SOD) were evaluated in serum. Placental expression of nuclear factor erythroid 2-related factor 2 (Nrf2), Kelch-like ECH-associated protein-1 (Keap1), and NAD(P)H quinone oxidoreductase 1 (NQO1) was examined using real-time quantitative PCR (RT-qPCR) and Western blot. RESULTS: The findings demonstrated that Astragalus treatment alleviated maternal pathological manifestations and ameliorated adverse fetal outcomes in the PE model. These protective effects were partly mediated by its antioxidant properties, which involved activation of the Nrf2/Keap1/NQO1 pathway. CONCLUSION: The results indicate that Astragalus holds promise as a therapeutic candidate for novel PE treatment strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Obstetrics, First Clinical College of Shanxi Medical University, Taiyuan, Shanxi Province, PR China.
- Department of Obstetrics, First Clinical College of Shanxi Medical University, Taiyuan, Shanxi Province, PR China. Electronic address: yanghailan100@163.com.
Förderung
- Non-US Government Research Support type
- Shanxi Province Natural Science Foundation
- Shanxi Medical University
- Health Commission of Shanxi Province
Zitieren
APA
Yang, L., Zhang, G., Ren, X., Hao, H., Zhang, X., Xu, M., Zhang, N., Zhang, R., & Yang, H. (2025). Astragalus ameliorates oxidative stress in rat models of preeclampsia through the Nrf2/Keap1/NQO1 pathway. Placenta, 168, 232-239. https://doi.org/10.1016/j.placenta.2025.07.004
Vancouver
Yang L, Zhang G, Ren X, Hao H, Zhang X, Xu M, et al. Astragalus ameliorates oxidative stress in rat models of preeclampsia through the Nrf2/Keap1/NQO1 pathway. Placenta. 2025;168:232-239. doi:10.1016/j.placenta.2025.07.004
BibTeX
@article{Yang2025,
author = {Yang, Lijun and Zhang, Guohua and Ren, Xiaorui and Hao, Huiniu and Zhang, Xu and Xu, Miao and Zhang, Nan and Zhang, Ruidan and Yang, Hailan},
title = {Astragalus ameliorates oxidative stress in rat models of preeclampsia through the Nrf2/Keap1/NQO1 pathway},
journal = {Placenta},
year = {2025},
volume = {168},
pages = {232--239},
doi = {10.1016/j.placenta.2025.07.004}
}
EUVIMED